AI Article Synopsis

  • Combined internal medicine-pediatrics (med-peds) residency offers a unique training pathway, accredited since 1967, with over 10,000 graduates.
  • Med-peds graduates can enter combined fellowships, reducing training time by one year compared to separate fellowships.
  • The review discusses the benefits and challenges of pursuing combined fellowship training in fields like pulmonary and critical care medicine, along with steps for board certification.

Article Abstract

Combined internal medicine-pediatrics (med-peds) training has been recognized as a unique, Accreditation Council for Graduate Medical Education-accredited residency pathway since 1967, resulting in more than 10,000 graduates. Med-peds graduates have the option of pursuing combined med-peds fellowships with a 1-year reduction in training time compared with pursuing such fellowships separately. The typical med-peds resident spends 8-9 months in the intensive care unit during residency, with additional rotations in pulmonary medicine; not surprisingly, residents are increasingly inquiring about combined med-peds fellowship training within the fields of pulmonary and critical care medicine. In this review, we outline both the advantages and challenges of such training and present various pathways and considerations to achieve board certification.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11448939PMC
http://dx.doi.org/10.34197/ats-scholar.2023-0135PSDOI Listing

Publication Analysis

Top Keywords

pulmonary critical
8
critical care
8
care medicine
8
combined med-peds
8
med-peds
5
opportunities pulmonary
4
medicine
4
medicine dual-trained
4
dual-trained medicine
4
medicine pediatric
4

Similar Publications

Navigating the Progression of COPD.

Am J Respir Crit Care Med

January 2025

Brigham and Women's Hospital, Division of Pulmonary and Critical Care Medicine, Boston, Massachusetts, United States.

View Article and Find Full Text PDF

Rett syndrome (RTT) is a neurodevelopmental disorder caused by mutations in the gene, potentially disrupting lipid metabolism and leading to dyslipidemia (DLD) and steatotic liver disease (SLD). Although SLD has been described in RTT mouse models, it remains undocumented in humans. We herein describe a 24-year-old woman with RTT who was evaluated for abnormal liver enzymes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!